Home

Собственик приспадне баланс ceramide insulin nature communications 2019 по избор Сключи договор коза

SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature  Communications
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature Communications

Resilient hepatic mitochondrial function and lack of iNOS dependence in  diet-induced insulin resistance - PLOS ONE - X-MOL
Resilient hepatic mitochondrial function and lack of iNOS dependence in diet-induced insulin resistance - PLOS ONE - X-MOL

Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes  Mellitus: Trends in Endocrinology & Metabolism
Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus: Trends in Endocrinology & Metabolism

PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced  Lipotoxicity in Muscle Cells | Semantic Scholar
PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar

PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced  Lipotoxicity in Muscle Cells | Semantic Scholar
PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar

IJMS | Free Full-Text | Sphingolipid Metabolism: New Insight into Ceramide-Induced  Lipotoxicity in Muscle Cells | HTML
IJMS | Free Full-Text | Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | HTML

Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic  vulnerability of prostate cancer | Nature Communications
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer | Nature Communications

Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism  | Nature Communications
Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism | Nature Communications

A selective inhibitor of ceramide synthase 1 reveals a novel role in fat  metabolism | Nature Communications
A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism | Nature Communications

Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance  through targeting TAK1-dependent signalling.,Nature Communications - X-MOL
Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.,Nature Communications - X-MOL

Metabolic Messengers: ceramides | Nature Metabolism
Metabolic Messengers: ceramides | Nature Metabolism

The role of C16:0 ceramide in the development of obesity and type 2 diabetes:  CerS6 inhibition as a novel therapeutic approach - ScienceDirect
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach - ScienceDirect

Role of ceramides in the pathogenesis of diabetes mellitus and its  complications - ScienceDirect
Role of ceramides in the pathogenesis of diabetes mellitus and its complications - ScienceDirect

Publications | Holthuis Lab | Molecular Cell Biology Division | Universität  Osnabrück
Publications | Holthuis Lab | Molecular Cell Biology Division | Universität Osnabrück

Sphingolipids produced by gut bacteria enter host metabolic pathways  impacting ceramide levels | Nature Communications
Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels | Nature Communications

PDF) Brain leptin reduces liver lipids by increasing hepatic triglyceride  secretion and lowering lipogenesis
PDF) Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis

A Ceramide-Centric View of Insulin Resistance: Cell Metabolism
A Ceramide-Centric View of Insulin Resistance: Cell Metabolism

SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature  Communications
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature Communications

The role of C16:0 ceramide in the development of obesity and type 2 diabetes:  CerS6 inhibition as a novel therapeutic approach - ScienceDirect
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach - ScienceDirect

Targeting a ceramide double bond improves insulin resistance and hepatic  steatosis | Science
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis | Science

Targeting a ceramide double bond improves insulin resistance and hepatic  steatosis | Science
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis | Science

Sphingolipids produced by gut bacteria enter host metabolic pathways  impacting ceramide levels | Nature Communications
Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels | Nature Communications

Ceramides – Lipotoxic Inducers of Metabolic Disorders: Trends in  Endocrinology & Metabolism
Ceramides – Lipotoxic Inducers of Metabolic Disorders: Trends in Endocrinology & Metabolism

Dynamic changes of muscle insulin sensitivity after metabolic surgery | Nature  Communications
Dynamic changes of muscle insulin sensitivity after metabolic surgery | Nature Communications